Report #2840735

Received May 13, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: AZ
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Skin lesion

Symptom narrative

open sores on 90 percent of my body; This non-serious case was reported by a consumer via call center representative and described the occurrence of skin lesion in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, 3 months after receiving Shingrix, the patient experienced skin lesion (Verbatim: open sores on 90 percent of my body). The outcome of the skin lesion was not reported. It was unknown if the reporter considered the skin lesion to be related to Shingrix. It was unknown if the company considered the skin lesion to be related to Shingrix. Additional Information: GSK Receipt Date: 03-MAY-2025 and 05-MAY-2025 The patient had developed open sores on 90 percent of body. These started 3 months after Shingrix vaccines.